PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
28-Oct-2024 Almirall´s 2024 Immunoskin conference hosts leading experts in inflammatory skin conditions to advance science and treatment options Almirall
28-Oct-2024 Global Barrett’s Esophagus with Dysplasia Treatment Market to Reach USD 7.54 Million by 2033 at a 5.3% of CAGR Amid Rising Focus on Cancer Prevention MARKITWIRED
28-Oct-2024 UPM Biomedicals launches FibGel™ the world’s first injectable nanocellulose hydrogel for medical devices UPM Biomedicals
28-Oct-2024 Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis AstraZeneca
28-Oct-2024 Global Axial Spondyloarthritis Management Market to Reach USD 7.3 Billion by 2033 at a 5.1% of CAGR Amid Rising Prevalence and Demand for Effective Treatments MARKITWIRED
28-Oct-2024 Global Adrenal Crisis Management Market value USD 6.31 Million Expected to Double by 2033 at a 6.7% CAGR , Driven by Rising Cases of Adrenal Insufficiency and Advancements in Treatment MARKITWIRED
28-Oct-2024 Innovative Trials named a top UK women-powered company in clinical research Innovative Trials
28-Oct-2024 Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 2025 Ottimo Pharma
28-Oct-2024 ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement ProQR
28-Oct-2024 Aston Institute for Membrane Excellence holds business showcase with Arup and Bruntwood SciTech in Birmingham Tech Week Aston Institute for Membrane Excellence
28-Oct-2024 Global Severe Hypertriglyceridemia (SHTG) Treatment Market Set to Reach USD 2675.37 Million by 2033 at a 14.3% CAGR Amid Rising Prevalence and Advancements in Therapeutics MARKITWIRED
28-Oct-2024 Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance Sanofi
28-Oct-2024 Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule Orion Corporation
28-Oct-2024 Collaborative Breakthrough in Lung-on-Chip Technology Vitrocell
28-Oct-2024 Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI Regeneron
28-Oct-2024 Global Stuttering Therapeutics Market to Reach USD 159.41 Million by 2033 with a 14% CAGR MARKITWIRED
28-Oct-2024 Radiotherapy-Induced Oral Mucositis Treatment Market Projected to Surpass USD 1,626.0 Million by 2034 at a 3.8% of CAGR , Driven by Rising Cancer Cases and Increased Radiotherapy Use MARKITWIRED
28-Oct-2024 Tharimmune Presents Favorable TH104 Phase 1 Clinical Data at the American College of Gastroenterology 2024 Annual Scientific Meeting AccessWire
28-Oct-2024 MentalHealth.com Launches Mental Health Network AccessWire
28-Oct-2024 Global Secondary Myelofibrosis Therapeutics Market Poised to Reach USD 2.74 Million by 2033 with a 6.3% CAGR Amid Rising Disease Incidence and Therapeutic Advancements MARKITWIRED